Page last updated: 2024-11-04

terfenadine and Emesis

terfenadine has been researched along with Emesis in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
" Before the amendment, assessments included physical examination, vital signs reporting (oral temperature, heart rate, and respiratory rate), and adverse event (AE) reporting."2.73Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. ( Hampel, FC; Kittner, B; Lanier, R; Milgrom, H, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milgrom, H1
Kittner, B1
Lanier, R1
Hampel, FC1

Trials

1 trial available for terfenadine and Emesis

ArticleYear
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007, Volume: 99, Issue:4

    Topics: Age Factors; Anti-Allergic Agents; Body Temperature; Child, Preschool; Cough; Double-Blind Method; E

2007